Clonal Dynamics of BRAF-Driven Drug Resistance in EGFR-Mutant Lung Cancer

Complementary functional analyses of polyclonal EGFR-mutant cell pools showed a dose-dependent enrichment of BRAF^V600E and a loss of EGFR inhibitor susceptibility.